National Research (NASDAQ:NRC) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why
by Tristan Rich · The Markets DailyShares of National Research Corporation (NASDAQ:NRC – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $16.04 and traded as high as $17.38. National Research shares last traded at $17.05, with a volume of 55,693 shares traded.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings lowered National Research from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, March 6th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.
Get Our Latest Analysis on NRC
National Research Stock Down 3.3%
The business has a 50 day moving average of $15.54 and a 200 day moving average of $16.05. The company has a debt-to-equity ratio of 5.36, a current ratio of 0.55 and a quick ratio of 0.55. The firm has a market capitalization of $374.85 million, a price-to-earnings ratio of 32.96 and a beta of 0.39.
National Research (NASDAQ:NRC – Get Free Report) last issued its earnings results on Tuesday, February 3rd. The company reported $0.16 EPS for the quarter. The business had revenue of $35.19 million during the quarter. National Research had a return on equity of 103.84% and a net margin of 8.44%.
National Research Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, April 10th. Investors of record on Friday, March 27th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.9%. The ex-dividend date was Friday, March 27th. National Research’s dividend payout ratio is presently 128.00%.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of NRC. Russell Investments Group Ltd. raised its stake in shares of National Research by 85.6% in the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after purchasing an additional 921 shares in the last quarter. EverSource Wealth Advisors LLC grew its position in National Research by 9,535.3% in the second quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock valued at $28,000 after acquiring an additional 1,621 shares during the period. BNP Paribas Financial Markets grew its position in National Research by 85.4% in the third quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock valued at $32,000 after acquiring an additional 1,150 shares during the period. Strs Ohio bought a new stake in National Research in the first quarter valued at $33,000. Finally, Raymond James Financial Inc. bought a new stake in National Research in the second quarter valued at $34,000. 47.26% of the stock is currently owned by institutional investors and hedge funds.
About National Research
National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.
Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.